Formulation and Delivery

Oral Delivery of Peptides and Proteins – Challenges & Opportunities

Partner Presentation Speaker(s)

• 

  Anil Kane, PhD

  Global Head of Technical & Scientific Affairs
  Thermo Fisher Scientific
  Mississauga, Ontario, Canada

Peptide therapeutics are gaining immense traction due to their specificity, potency, and lower toxicity, making them invaluable in the treatment of various conditions such as metabolic disorders, cancers, and autoimmune diseases. Despite their promise, one major hurdle remains: effective oral delivery. Traditionally administered via injections due to poor oral bioavailability, there is growing interest in overcoming the barriers to allow peptides to be taken orally, which could significantly enhance patient compliance and widen therapeutic applications
Key Takeaways:
• Understanding the major barriers to oral peptide delivery and the scientific principles behind them.
• Insights into cutting-edge technologies and innovations that are transforming the oral peptide landscape.
• The future outlook for peptide therapeutics and their potential for expanded therapeutic applications via oral administration.
• Strategic approaches to navigating regulatory frameworks and accelerating the development of oral peptide therapies.